Bioventus Inc. director Pat Beyer reported receiving a grant of 25,146 restricted stock units (RSUs) on June 3, 2026. Prior to this, on June 2, 2026, 32,282 previously granted RSUs vested and were converted into Class A common stock. Following these transactions, Pat Beyer directly holds 108,718 Class A common shares and 25,146 outstanding RSUs.

Yusri Elsayed, SVP & Global Oncology Therapeutic Area Head at Johnson & Johnson Innovative Medicine, expressed his deep gratitude to his teams and collaborators following the 2026 ASCO Annual Meeting. He highlighted Johnson & Johnson's extraordinary innovations showcased at the event, including data for ERLEADA, Rybrevant, and Tecvayli. Elsayed emphasized the company's unwavering commitment to improving and extending the lives of cancer patients and working towards eliminating cancer.

Shares of INVESCO Ltd. (IVZ) rose 4.57% to $28.17 on Thursday, outperforming the broader market. This gain snapped a three-day losing streak for the stock. The S&P 500 Index and Dow Jones Industrial Average also saw gains during the strong trading session.

International Paper (NYSE: IP) has completed its $360 million acquisition of North Pacific Paper Company (NORPAC), a West Coast packaging business. This acquisition aims to enhance system flexibility, expand capabilities for lightweight, high-performance packaging, and improve service to West Coast customers. The deal aligns with International Paper's strategic transformation to maximize value for its stakeholders and strengthen its position in the packaging market.

Plug Power announced that its Class I director, Kavita Mahtani, will resign from its board on June 11, 2026, to take on a new executive role at Wells Fargo. Her departure is not due to any dispute with Plug Power's operations. Despite this, TipRanks' AI Analyst, Spark, rates PLUG as Neutral due to weak financial performance, though technicals show an uptrend and the company has a defined path to profitability.

eBay Inc. shares traded roughly flat on the Nasdaq on June 4, 2026, after the latest quarterly dividend, indicating that investors view the company as a mature, income-generating tech firm. With a market capitalization of approximately USD 41.23 billion as of January 30, 2026, eBay remains a significant player in international e-commerce, positioned as an established platform shifting from a high-growth internet pioneer. The company's stable share price and regular dividends appeal to income-focused investors, even as it navigates intense competition in the global e-commerce sector.

BGE-102, a novel NLRP3 inhibitor developed by BioAge Labs (BIOA), showed promising results in Phase I with strong biomarker reductions and excellent tolerability. Phase II trials are currently underway for cardiovascular and DME indications, and the program is well-funded. Pivotal data and potential Phase III enablement are anticipated by the end of the year.

Bio Green Med Solution Inc (BGMS) has announced the acquisition of Future NRG Sdn. Bhd. in an all-stock transaction, aiming to enhance its capabilities in sustainable medical waste management and waste-to-energy initiatives. Following the announcement, BGMS shares surged by 225% in after-hours trading, despite a GuruFocus score of 48/100 and a low profitability rating. Investors are advised to consider the mixed signals, including significant insider selling, when evaluating this growth opportunity.

Broadcom's shares plunged over 12% after its fiscal Q2 results and AI guidance, despite showing strong growth, disappointed high investor expectations. The company reported record earnings and revenue, forecasting 84% year-over-year growth for Q3, but its stock, which had soared pre-report, still trades at a forward P/E of 37. The article suggests this drop could be a compelling entry point for long-term investors given its strong prospects in the AI sector.

Johnson & Johnson (NYSE:JNJ) shares rose 2.3% due to positive news, including strong Phase 2 results for nipocalimab in lupus and Sjögren’s disease, and a raised quarterly dividend. The company also announced a quarterly dividend increase to $1.34 per share. Analysts maintain a consensus "Moderate Buy" rating with a target price of $253.04.